Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,767 public trials 1,061 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

NCT00655876

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • Arizona Oncology - Tucson Tucson, Arizona, United States
  • Auburn Radiation Oncology Auburn, California, United States
  • Radiation Oncology Centers - Cameron Park Cameron Park, California, United States
  • Mercy Cancer Center at Mercy San Juan Medical Center Carmichael, California, United States
View all 175 locations
View Trial Details
Completed

Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma

NCT02775812

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Sutter Medical Center Sacramento Sacramento, California, United States
View all 69 locations
View Trial Details
Completed

Studies of Elevated Parathyroid Activity

NCT00001277

Conditions
Calcium Metabolism Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, +19 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

NCT01884259

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +16 more
Locations
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • Landesklinikum Krems Krems, Austria
  • Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria
  • Kepler Universitätsklinikum, Med Campus III. Klinik für Interne 3 - Schwerpunkt Hämatologie u. Onkologie Linz, Austria
View Trial Details
Completed

A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

NCT04936399

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Local Institution - 0006 Truro, Cornwall, United Kingdom
  • Local Institution London, Greater London, United Kingdom
  • Local Institution Maidstone, Kent, United Kingdom
  • Local Institution Glasgow, Lanarkshire, United Kingdom
View all 36 locations
View Trial Details
Completed

Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma

NCT03409848

Conditions
Adenocarcinoma Gastric, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • Gesundheitszentrum St. Marien Amberg - MVZ Amberg, Germany
  • Gesundheitszentrum Wetterau - Facharztzentrum Bad Nauheim, Germany
  • Helios Klinikum Bad Saarow - Hämatologie, Onkologie und Palliativmedizin Bad Saarow, Germany
  • Charité Universitätsmedizin Campus Virchow Klinikum - Hämatologie / Onkologie Berlin, Germany
View all 35 locations
View Trial Details

Related conditions